State-owned Sinopharm promotes TCM mixed ownership reform
Share - WeChat
Sinopharm, a large medicine group controlled by China’s State-owned Asset Supervision and Administration Commission of the State Council, is promoting mixed ownership reform in its Traditional Chinese Medicine (TCM) branch.
“Sinopharm has been a pilot of mixed ownership reform and accumulated lots of experience in the field,” said Zeng Bing, deputy general manager of Sinopharm.
“Traditional Chinese Medicine now is developing rapidly, and great efforts of mixed ownership reform will be continuously put on this area when we boost the whole industrial chain layout.”
- Ziyang Fuxi Tea makes international debut in Kazakhstan
- Haileybury Tianjin thrives with Beijing-Tianjin-Hebei development strategies
- Fruitful results for South East Asian nations and China since 2016 agreement
- WKU hosts Sino-US Entrepreneur Roundtable
- China hopes US can view China's development in positive light: Xi
- China-UK ELT partnership set